Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 70.2 TWD
Market Cap: 8.4B TWD
Have any thoughts about
Formosa Laboratories Inc?
Write Note

Formosa Laboratories Inc
Investor Relations

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Chen-Yu Cheng Ph.D.
President & Chairman of the Board
No Bio Available
Ms. S. J. Liou B.S.
Senior Vice President of Business
No Bio Available
Ms. Michelle Lo
Senior Vice President of Corporate Support Division
No Bio Available
Mr. Hengui Huang
Senior Vice President of Quality & Regulatory Compliance Division
No Bio Available
Mr. Hank Chen
Senior Vice President of Production
No Bio Available
Ling-Fang Yang
Vice President
No Bio Available
Chien-Fei Lin
Chief Information Security Officer
No Bio Available

Contacts

Address
TAOYUAN
TAOYUAN
No.36, Hoping Street, Kengkou Village, Luzhu District
Contacts